Literature DB >> 10770816

Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line.

S Varsano1, M Kaminsky, M Kaiser, L Rashkovsky.   

Abstract

BACKGROUND: The interrelationship between human airway epithelium and complement proteins may affect airway defence, airway function, and airway epithelial integrity. A study was undertaken to determine (1) whether unstimulated human bronchial epithelium generates complement proteins and expresses cell membrane complement inhibitory proteins (CIP) and (2) whether stimulation by proinflammatory cytokines affects the generation of complement and expression of cell membrane CIP by these cells.
METHODS: Human bronchial epithelium cell line BEAS-2B was cultured in a serum-free medium. Cells were incubated with and without proinflammatory cytokines to assess unstimulated and stimulated generation of complement C3, C1q and C5 (by ELISA), and to examine the expression of cell membrane CIP decay accelerating factor (DAF; CD55), membrane cofactor protein (MCP; CD46), and CD59 (protectin) by flow cytometry analysis.
RESULTS: Unstimulated human bronchial epithelial cell line BEAS-2B in serum-free medium generates complement C3 (mean 32 ng/10(6) cells/72 h, range 18-52) but not C1q and C5, and expresses cell membrane DAF, MCP, and CD59. Interleukin (IL)-1alpha (100 U/ml/72 h) and tumour necrosis factor (TNF-alpha; 1000 U/ml/72 h) increased generation of C3 up to a mean of 78% and 138%, respectively, above C3 generation by unstimulated cells. DAF was the only cell membrane CIP affected by cytokine stimulation. Interferon (IFN)-gamma (10 U/ml/72 h) and TNF-alpha (1000 U/ml/72 h) increased DAF expression up to a mean of 116% and 45%, respectively, above that in unstimulated cells. MCP and CD59 expression was not consistently affected by IL-1alpha, TNF-alpha, or IFN-gamma.
CONCLUSIONS: Local generation of complement C3 and expression of cell membrane CIP by human bronchial epithelium and its modulation by proinflammatory cytokines might be an additional regulatory mechanism of local airway defence and may affect airway function and epithelial integrity in health and disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770816      PMCID: PMC1745745          DOI: 10.1136/thorax.55.5.364

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  30 in total

1.  Complement C3 receptors: structure and function.

Authors:  M A Arnaout; H R Colten
Journal:  Mol Immunol       Date:  1984-12       Impact factor: 4.407

2.  Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

Authors:  R C Strunk; D M Eidlen; R J Mason
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement.

Authors:  R R Kew; B Ghebrehiwet; A Janoff
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

4.  The complement fragment C3d facilitates phagocytosis by monocytes.

Authors:  T A Gaither; I Vargas; S Inada; M M Frank
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

Review 5.  Biochemistry and biology of anaphylatoxins.

Authors:  T E Hugli
Journal:  Complement       Date:  1986

6.  Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers.

Authors:  D Y Bell; J A Haseman; A Spock; G McLennan; G E Hook
Journal:  Am Rev Respir Dis       Date:  1981-07

7.  Effect of lipopolysaccharide on C3 and C5 production by human lung cells.

Authors:  B L Rothman; M Merrow; A Despins; T Kennedy; D L Kreutzer
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

8.  Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines.

Authors:  S Varsano; L Rashkovsky; H Shapiro; J Radnay
Journal:  Am J Respir Cell Mol Biol       Date:  1998-09       Impact factor: 6.914

9.  Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.

Authors:  R B Fick; R A Robbins; S U Squier; W E Schoderbek; W D Russ
Journal:  Pediatr Res       Date:  1986-12       Impact factor: 3.756

10.  Decay-accelerating factor functions as a signal transducing molecule for human T cells.

Authors:  L S Davis; S S Patel; J P Atkinson; P E Lipsky
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

View more
  16 in total

1.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

Review 2.  Complement system in lung disease.

Authors:  Pankita H Pandya; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

3.  Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response.

Authors:  Tao Peng; Liming Hao; Joseph A Madri; Xiao Su; Jack A Elias; Gregory L Stahl; Stephen Squinto; Yi Wang
Journal:  J Clin Invest       Date:  2005-05-12       Impact factor: 14.808

4.  Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death.

Authors:  Hrishikesh S Kulkarni; Michelle L Elvington; Yi-Chieh Perng; M Kathryn Liszewski; Derek E Byers; Christopher Farkouh; Roger D Yusen; Deborah J Lenschow; Steven L Brody; John P Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-02       Impact factor: 6.914

5.  SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation.

Authors:  Rachel E Lamerton; Edith Marcial-Juarez; Sian E Faustini; Marisol Perez-Toledo; Margaret Goodall; Siân E Jossi; Maddy L Newby; Iain Chapple; Thomas Dietrich; Tonny Veenith; Adrian M Shields; Lorraine Harper; Ian R Henderson; Julie Rayes; David C Wraith; Steve P Watson; Max Crispin; Mark T Drayson; Alex G Richter; Adam F Cunningham
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

6.  Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response.

Authors:  Fatoumata B Sow; Jack M Gallup; David K Meyerholz; Mark R Ackermann
Journal:  Dev Comp Immunol       Date:  2009-02-02       Impact factor: 3.636

Review 7.  The complement system in the airway epithelium: An overlooked host defense mechanism and therapeutic target?

Authors:  Hrishikesh S Kulkarni; M Kathryn Liszewski; Steven L Brody; John P Atkinson
Journal:  J Allergy Clin Immunol       Date:  2018-01-12       Impact factor: 10.793

Review 8.  Role of innate immunity in the pathogenesis of chronic rhinosinusitis: progress and new avenues.

Authors:  Cornelis M van Drunen; Jenny M Mjösberg; Christine L Segboer; Marjolein E Cornet; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 9.  Anaphylatoxin C3a receptors in asthma.

Authors:  Hydar Ali; Reynold A Panettieri
Journal:  Respir Res       Date:  2005-02-21

10.  Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms.

Authors:  Ludmila Alekseeva; Dominique Huet; Françoise Féménia; Isabelle Mouyna; Mahdia Abdelouahab; Adrien Cagna; Daniel Guerrier; Virginie Tichanné-Seltzer; Armelle Baeza-Squiban; René Chermette; Jean-Paul Latgé; Nadia Berkova
Journal:  BMC Microbiol       Date:  2009-02-11       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.